Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
Submitted by
admin
on October 1, 2012 - 9:52pm
Source:
Seekin Alpha
News Tags:
M&A
AstraZeneca
Seattle Genetics
Regeneron
ONYX Pharmaceuticals
Biomarin
Forest Labs
Headline:
AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
Do Not Allow Advertisers to Use My Personal information
